Earnings Preview: Aethlon Medical
Portfolio Pulse from Benzinga Insights
Aethlon Medical (NASDAQ:AEMD) is scheduled to release its quarterly earnings report on February 14, 2024, with an expected EPS of $-1.23. Historically, the company has had mixed results in beating EPS estimates, with a notable 7.55% share price increase following last quarter's earnings beat. However, shares have declined 67.61% over the last year, indicating bearish sentiment among long-term shareholders. Investors will be keenly watching for not only the earnings outcome but also the company's future guidance.
February 13, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aethlon Medical is expected to report an EPS of $-1.23 for the upcoming quarter. Historical data shows mixed reactions to earnings reports, with a significant share price increase following the last quarter's beat. However, the overall yearly performance is down 67.61%, indicating bearish sentiment.
Given Aethlon Medical's mixed historical earnings performance and the significant decline in share price over the past year, the short-term impact of the upcoming earnings report is uncertain. While a positive earnings beat and guidance could provide a short-term boost, the overall bearish sentiment may limit gains. The score is neutral due to these conflicting factors.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100